Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

Louis P. Garrison, Deborah Lubeck, Deepa Lalla, Virginia Paton, Amylou Dueck, Edith A. Perez

Research output: Contribution to journalArticlepeer-review

88 Scopus citations

Fingerprint Dive into the research topics of 'Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences